Cellbxhealth (LON:CLBX) Posts Earnings Results

Cellbxhealth (LON:CLBX) announced its quarterly earnings results on Monday. The company reported GBX (5.51) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 135 million for the quarter.

Cellbxhealth Trading Down 0.6%

Shares of CLBX opened at GBX 1.52 on Wednesday. Cellbxhealth has a twelve month low of GBX 0.85 and a twelve month high of GBX 2.70. The stock has a market cap of £29.52 million and a price-to-earnings ratio of -0.32.

Cellbxhealth Company Profile

CelLBxHealth plc is a precision CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology. Its patent-protected Parsortix® platform harvests CTCs from blood and can be integrated with existing laboratory instruments for comprehensive downstream analysis – including whole-cell imaging, proteomic profiling and full genomic workflows.
Commercial activities centre on (1) Product Sales: Accelerating Parsortix platform adoption and consumable sales through CROs and clinical lab partnerships.